Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Cyclospora parasite illnesses have affected 28 NC counties, sickened more than 200 people
Recommended
UNC has a new chancellor. Why interim Lee Roberts got the permanent job.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Co-Diagnostics Inc
(NQ:
CODX
)
1.365
+0.125 (+10.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Co-Diagnostics Inc
< Previous
1
2
3
4
5
Next >
CODX Stock Earnings: Co-Diagnostics Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
CODX stock results show that Co-Diagnostics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 10, 2024
Via
Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via
Benzinga
Peering Into Co-Diagnostics's Recent Short Interest
April 02, 2024
Via
Benzinga
Co-Diagnostics: Q4 Earnings Insights
March 14, 2024
Via
Benzinga
Earnings Preview: Co-Diagnostics
March 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 06, 2024
Via
Benzinga
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
CODX Stock Earnings: Co-Diagnostics Misses EPS, Misses Revenue for Q4 2023
March 14, 2024
CODX stock results show that Co-Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
November 10, 2023
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.
Via
Benzinga
Exposures
COVID-19
Preview: Co-Diagnostics's Earnings
May 10, 2023
Via
Benzinga
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Co-Diagnostics Earnings Perspective: Return On Invested Capital
March 17, 2023
Via
Benzinga
Preview: Co-Diagnostics's Earnings
March 15, 2023
Via
Benzinga
7 Doomed Growth Stocks Destined for Disaster
July 12, 2023
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell.
Via
InvestorPlace
Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday
May 12, 2023
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 08, 2023
Via
Benzinga
Co-Diagnostics's Earnings Outlook
November 09, 2022
Co-Diagnostics (NASDAQ:CODX) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023
March 20, 2023
Via
Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.
Via
InvestorPlace
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
Co-Diagnostics's Return On Capital Employed Overview
September 07, 2022
Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) reported Q2 sales of $5.02 million. Earnings fell to a loss of $2.69 million, resulting in a 122.93% decrease from last quarter.
Via
Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
Mizuho Increases PT On ON Semiconductor, Charter Communications Price Target Cut By 37%
August 15, 2022
Atlantic Equities lowered the price target on Charter Communications, Inc. (NASDAQ: CHTR) from $755 to $477. Charter Communications shares fell 1.7% to $470.00 in pre-market trading.
Via
Benzinga
This Analyst Boosts Price Target On Dillard's; Also Check Out Some Other Big PT Changes
August 15, 2022
JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
August 15, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.